Loading stock data…
$90.99+1.04 (+1.16%)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally.
Colgate-Palmolive Company in the Consumer Defensive sector is trading at $90.99 with a market capitalization of $73.3B. Wall Street consensus targets $98.25 (20 analysts), implying a +8.0% move over the next 12 months. The stock is currently 8% below its 52-week high of $99.33, remaining 3.1% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $5.36B↑ | $5.32B↑ | $5.23B↑ | $5.13B↑ | $5.11B |
| Gross Profit | $3.30B↑ | $3.23B↑ | $3.15B↑ | $3.05B↓ | $3.07B |
| Operating Income | $1.02B↑ | $964.00M↓ | $1.02B↓ | $1.06B↓ | $1.08B |
| Net Income | $693.00M↑ | $646.00M↑ | -$37.00M↓ | $735.00M↓ | $743.00M |
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Ho...
Academic risk and quality models computed from CL's own filings and price history, not from analyst opinion.
Mixed: 5 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
GARCH(1,1) 30-day annualised forecast, above the current 20.6% reading.
Fama-French 5-factor market beta. The five factors explain 25% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-13.